Phibro Animal Health (NASDAQ:PAHC) Hits New 12-Month High at $18.72

Shares of Phibro Animal Health Co. (NASDAQ:PAHCGet Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $18.72 and last traded at $18.70, with a volume of 75429 shares trading hands. The stock had previously closed at $17.60.

Wall Street Analysts Forecast Growth

PAHC has been the topic of a number of recent analyst reports. StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Tuesday, April 9th. Barclays boosted their price target on shares of Phibro Animal Health from $10.00 to $13.00 and gave the stock an “underweight” rating in a research report on Friday, May 10th. Two analysts have rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus target price of $14.75.

View Our Latest Report on PAHC

Phibro Animal Health Trading Down 1.0 %

The firm has a 50-day moving average of $17.64 and a 200 day moving average of $14.37. The company has a market cap of $762.67 million, a P/E ratio of 58.84, a price-to-earnings-growth ratio of 4.99 and a beta of 0.57. The company has a current ratio of 3.16, a quick ratio of 1.67 and a debt-to-equity ratio of 1.69.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last posted its quarterly earnings results on Wednesday, May 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The firm had revenue of $263.20 million for the quarter, compared to analysts’ expectations of $251.82 million. Phibro Animal Health had a return on equity of 17.11% and a net margin of 1.32%. On average, analysts predict that Phibro Animal Health Co. will post 1.13 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 5th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.55%. The ex-dividend date was Wednesday, June 5th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 150.00%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in PAHC. Dynamic Advisor Solutions LLC bought a new stake in shares of Phibro Animal Health during the fourth quarter valued at approximately $208,000. China Universal Asset Management Co. Ltd. increased its stake in Phibro Animal Health by 358.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock valued at $27,000 after purchasing an additional 1,843 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in Phibro Animal Health by 19.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 8,500 shares of the company’s stock worth $98,000 after buying an additional 1,370 shares during the last quarter. Williams & Novak LLC bought a new position in shares of Phibro Animal Health in the fourth quarter valued at $196,000. Finally, Louisiana State Employees Retirement System acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at about $118,000. 99.34% of the stock is owned by institutional investors and hedge funds.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Recommended Stories

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.